{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:18:23Z","timestamp":1779175103615,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001833","name":"VU University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003180","name":"Academic Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jdiacomp.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:50:39Z","timestamp":1530129039000},"page":"845-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The interrelation between FGF23 and glucose metabolism in humans"],"prefix":"10.1016","volume":"32","author":[{"given":"Stan R.","family":"Ursem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahel M.","family":"B\u00fcttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00ebtte T.","family":"Ackermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam M.","family":"Oosterwerff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M.V.","family":"Eekhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Lips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille J.","family":"Serlie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne E.","family":"la Fleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6712-9955","authenticated-orcid":false,"given":"Annemieke C.","family":"Heijboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0010","first-page":"1","article-title":"Bone as an endocrine organ","volume":"14","author":"Fukumoto","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00424-003-1084-1","article-title":"Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na\/Pi transporter","volume":"446","author":"Segawa","year":"2003","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0030","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0040","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2215\/CJN.02740311","article-title":"Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study","volume":"6","author":"Guti\u00e9rrez","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058961","article-title":"Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations","volume":"8","author":"Fern\u00e1ndez-Real","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdiacomp.2013.09.004","article-title":"Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3\u20135 chronic kidney disease patients","volume":"28","author":"Garland","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1515\/jpem-2012-0064","article-title":"The association of FGF23 levels in obese adolescents with insulin sensitivity","volume":"25","author":"Wojcik","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.2011.04299.x","article-title":"FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results","volume":"77","author":"Wojcik","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122885","article-title":"Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults","volume":"10","author":"Hanks","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","article-title":"Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans","volume":"25","author":"Ito","year":"2007","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3945\/ajcn.113.069260","article-title":"Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial","volume":"100","author":"Oosterwerff","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.27149","article-title":"Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial","volume":"60","author":"Koopman","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2215\/CJN.04730510","article-title":"Effects of dietary phosphate and calcium intake on fibroblast growth factor-23","volume":"6","author":"Vervloet","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1258\/acb.2009.009066","article-title":"Determination of fibroblast growth factor 23","volume":"46","author":"Heijboer","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0095","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0100","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/jc.2006-2865","article-title":"Determination of the elimination half-life of fibroblast growth factor-23","volume":"92","author":"Khosravi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0105","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/00365520601137272","article-title":"Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate","volume":"42","author":"Holst","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0110","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1365-2265.2007.03159.x","article-title":"Reduced attenuation of bone resorption after oral glucose in type 2 diabetes","volume":"68","author":"Chailurkit","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bone.2017.01.027","article-title":"Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects","volume":"97","author":"Westberg-Rasmussen","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","article-title":"Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice","volume":"26","author":"Hesse","year":"2007","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0130","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1210\/en.2011-1878","article-title":"Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor","volume":"153","author":"Streicher","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0026-0495(79)90063-5","article-title":"Effects of insulin infusion on plasma phosphate in diabetic patients","volume":"28","author":"Riley","year":"1979","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0140","first-page":"E616","article-title":"Insulin stimulates Pi transport in brush border vesicles from proximal tubular segments","volume":"247","author":"Hammerman","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0150","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Nishida","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0155","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1681\/ASN.2014121253","article-title":"Renal clearance of mineral metabolism biomarkers","volume":"27","author":"van Ballegooijen","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0165","doi-asserted-by":"crossref","first-page":"F254","DOI":"10.1152\/ajprenal.00396.2016","article-title":"Interorgan handling of fibroblast growth factor-23 in humans","volume":"312","author":"Verzola","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1371\/journal.pone.0066395","article-title":"Oral but not intravenous glucose acutely decreases circulating interleukin-6 concentrations in overweight individuals","volume":"8","author":"Manning","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2018.06.013_bb0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/00365513.2011.640407","article-title":"Acute hyperinsulinemia is followed by increased serum concentrations of fibroblast growth factor 23 in type 2 diabetes patients","volume":"72","author":"Winther","year":"2012","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718303258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718303258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:26Z","timestamp":1534809626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872718303258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1056872718303258"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.06.013","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interrelation between FGF23 and glucose metabolism in humans","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}